Home›People›Saro Passaro
SP

Saro Passaro

Director at Boltz, PBC

Director
Updated Nov 7, 2026·Latest SEC filing Oct 22, 2026·Suggest an edit

About Saro Passaro

Saro Passaro is a director of Boltz, PBC, a public benefit corporation that builds AI models for biology. Its Boltz Lab platform lets scientists use the company's models and agents for small-molecule and protein design. Passaro is named on the Boltz team list.

He is on the Boltz-1 team. The MIT Jameel Clinic announced that open-source model on November 16, 2024, in a post signed by Passaro, Gabriele Corso and Jeremy Wohlwend.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Saro Passaro in the role, so the role may have started earlier or lasted longer.

Boltz, PBC Current
Director
2026 – Present · Boston, MA
Boltz builds open-source and proprietary AI models, plus a platform and API, to predict and design small molecules and proteins.

Key Colleagues at Startups

The people Saro Passaro works with at each company, as listed on that company's latest Form D.

Boltz, PBC · Form D, Oct 22, 2026
Gabriele Corso
Gabriele Corso
Co-founder and CEO, director
Jeremy Wohlwend
Jeremy Wohlwend
Executive officer and director
DR
Dylan Reid
Director
AH
Andrew Hedin
Director

Sources

  1. SECBoltz, PBC Form D, filed Oct 22, 2026
  2. companyBoltz: Announcing Boltz (launch post)
  3. releasePR Newswire: Boltz and Pfizer collaboration release
  4. universityMIT Jameel Clinic: Introducing Boltz-1